BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

HeartSine Technologies, Inc Named One of the Most Innovative Businesses in the United Kingdom


9/6/2011 1:28:32 PM

NEWTOWN, Pa., Sept. 6, 2011 /PRNewswire/ --HeartSine® Technologies, Inc., a world leader in personal and public access defibrillators, announced that it is a finalist to receive the coveted Orange Innovation Award in the 10th annual UK National Business Awards. HeartSine was selected because of its innovative approach to the design, development and manufacture of Automated External Defibrillators (AED) for the treatment of Sudden Cardiac Arrest.

The Orange Innovation Award recognizes businesses that have gone beyond the ordinary in their development and who have implemented cutting edge innovation in terms of products, services or company culture. The clinically advanced technology within HeartSine's leading edge cardiac defibrillation products enables the company to compete successfully in the global healthcare market.

HeartSine's Public Access Defibrillator (PAD) devices meet and exceed AED clinical efficacy standards. This innovation enables HeartSine to provide its global customers with exceptional product reliability, the lowest cost of ownership and superior technology that helps save lives.

"Our long history of invention and innovation in the AED industry continues today in our ongoing commitment to developing and providing the highest level of clinically advanced, lifesaving technology to customers around the globe," said Marc Lawrence, senior vice president, HeartSine. "We are honored to have been selected as a finalist for this prestigious award."

HeartSine will prepare a presentation in person before an independent panel of experts in October. Winners will be announced in November at an awards ceremony in London.

About HeartSine Technologies

A world leader in personal and public access defibrillators, HeartSine's mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care. HeartSine® samaritan® PAD (Public Access Defibrillator) is the only medical device specifically designed for public access use to administer lifesaving treatment for Sudden Cardiac Arrest. It's lifesaving, pure and simple.

For more information, please contact info@heartsine.com, call (866) 478-7463, ext. 112, or visit www.heartsine.com.

Download a high-res photo of the samaritan® PAD 300P: http://www.ggcomm.com/HeartSine/PAD300P.jpg

121 Friends Lane
Suite 400
Newtown, PA 18940
Phone: 215.860.8100 ext. 112
Contact: Stacey Lock
stacey.lock@heartsine.com

SOURCE HeartSine Technologies, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES